GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (WBO:CVAC) » Definitions » Buildings And Improvements

CureVac NV (WBO:CVAC) Buildings And Improvements : €0.0 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Buildings And Improvements?

CureVac NV's quarterly buildings and improvements increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€28.2 Mil) but then declined from Dec. 2024 (€28.2 Mil) to Mar. 2025 (€0.0 Mil).

CureVac NV's annual buildings and improvements increased from Dec. 2022 (€26.5 Mil) to Dec. 2023 (€27.5 Mil) and increased from Dec. 2023 (€27.5 Mil) to Dec. 2024 (€28.2 Mil).


CureVac NV Buildings And Improvements Historical Data

The historical data trend for CureVac NV's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Buildings And Improvements Chart

CureVac NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buildings And Improvements
Get a 7-Day Free Trial 19.95 27.27 26.47 27.54 28.20

CureVac NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 28.20 -

CureVac NV Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


CureVac NV Business Description

Industry
Traded in Other Exchanges
Address
Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.